Literature DB >> 11074416

Challenges for protein chemical synthesis in the 21st century: bridging genomics and proteomics.

L P Miranda1, P F Alewood.   

Abstract

The Human Genome Project and other major sequencing projects have rapidly provided a vast array of new protein sequences. In the postgenomic era, the physical form of many of these gene-encoded sequences will be vital for biomedical research and drug development. In this epoch, the advantages of protein chemical synthesis will complement recombinant-DNA methods, and will be used to provide rapid access to small proteins or functional receptor domains. In this review the key methodological advances that have made the synthesis of long peptides and small proteins more effective will be presented. Focus is given to the issues and goals of contemporary chemical protein synthesis, including (1) the rapid chain assembly of tailored peptide segments for use in ligation strategies, and (2) development of highly efficient and universal chemoselective ligation strategies. Biopolymers (Pept Sci) 55: 217-226, 2000 Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074416     DOI: 10.1002/1097-0282(2000)55:3<217::AID-BIP40>3.0.CO;2-B

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  3 in total

1.  Mass-based fraction collection of crude synthetic peptides in analytical and preparative scale.

Authors:  Ralf Moritz; Nicola O'Reilly
Journal:  J Biomol Tech       Date:  2003-06

2.  Disulfide-Depleted Selenoconopeptides: a Minimalist Strategy to Oxidative Folding of Cysteine-Rich Peptides.

Authors:  Tiffany S Han; Min-Min Zhang; Konkallu Hanumae Gowd; Aleksandra Walewska; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  ACS Med Chem Lett       Date:  2010-05-03       Impact factor: 4.345

Review 3.  Advances in Fmoc solid-phase peptide synthesis.

Authors:  Raymond Behrendt; Peter White; John Offer
Journal:  J Pept Sci       Date:  2016-01       Impact factor: 1.905

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.